Coronavirus disease 2019 (COVID‑19) is an infectious disease that became a global health emergency. This review focuses on the aspects of COVID‑19 pertaining to rheumatology, including signs and symptoms akin to those observed in rheumatic disorders, risk of infection or severe course of the disease in patients with a pre‑ existing rheumatic disease and those receiving antirheumatic or immunosuppressive medication, as well as potential use of antirheumatic or anticytokine therapeutic strategies that are already applied in rheumatology (among others, chloroquine, hydroxychloroquine, tocilizumab, and baricitinib) in patients with COVID‑19.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.20452/pamw.15366 | DOI Listing |
Publication Analysis
Top Keywords
coronavirus disease
8
disease 2019
8
2019 concern
4
concern rheumatologists?
4
rheumatologists? coronavirus
4
disease
4
2019 covid‑19
4
covid‑19 infectious
4
infectious disease
4
disease global
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!